Extensive hypopigmentation after starting antiretroviral treatment in an human immunodeficiency virus (HIV)-seropositive African woman.
Kigonya
Catherina
C
Lutwama
Fred
F
Colebunders
Robert
R
D000328:Adult; D019380:Anti-HIV Agents / Q000009:adverse effects*; D000890:Anti-Infective Agents / Q000009:adverse effects; D005260:Female; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D017496:Hypopigmentation / Q000139:chemically induced* / Q000473:pathology; D019259:Lamivudine / Q000009:adverse effects; D019829:Nevirapine / Q000009:adverse effects; D010787:Photosensitivity Disorders / Q000139:chemically induced*; D012867:Skin / Q000473:pathology; D018119:Stavudine / Q000009:adverse effects; D015662:Trimethoprim, Sulfamethoxazole Drug Combination / Q000009:adverse effects
D019380:Anti-HIV Agents; D000890:Anti-Infective Agents; D019259:Lamivudine; D015662:Trimethoprim, Sulfamethoxazole Drug Combination; D019829:Nevirapine; D018119:Stavudine